Related references
Note: Only part of the references are listed.Diagnostic and Dosimetry Features of [64Cu]CuCl2 in High-Grade Paediatric Infiltrative Gliomas
Francesco Fiz et al.
MOLECULAR IMAGING AND BIOLOGY (2023)
Efficacy and Safety of the 64Cu(II)Cl2 PET/CT for Urological Malignancies Phase IIa Clinical Study
Manlio Mascia et al.
CLINICAL NUCLEAR MEDICINE (2021)
64CuCl2 PET/CT as a potential new imaging method in prostate cancer: illusion or reality?
Francesco Cantiello et al.
MINERVA UROLOGY AND NEPHROLOGY (2021)
Diagnostic value of retrospectively fused 64CuCl2 PET/MRI in biochemical relapse of prostate cancer: comparison with fused 18F-Choline PET/MRI, 64CuCl2 PET/CT, 18F-Choline PET/CT, and mpMRI
Francesco Paparo et al.
ABDOMINAL RADIOLOGY (2020)
The emerging value of 64Cu for molecular imaging and therapy
Cristina Bolzati et al.
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Adding 64Cu radiopharmaceuticals to the toolkit of molecular imaging
Gabriela Capriotti et al.
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Copper-64 Chloride Exhibits Therapeutic Potential in Three-Dimensional Cellular Models of Prostate Cancer
Catarina I. G. Pinto et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
64CuCl2 PET/CT in Prostate Cancer Relapse
Arnoldo Piccardo et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
The emerging role of copper-64 radiopharmaceuticals as cancer theranostics
Alessandra Boschi et al.
DRUG DISCOVERY TODAY (2018)
Copper radiopharmaceuticals for theranostic applications
Anife Ahmedova et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Radiobiological Characterization of (CuCl2)-Cu-64 as a Simple Tool for Prostate Cancer Theranostics
Joana Fernandes Guerreiro et al.
MOLECULES (2018)
The SGK1 Kinase Inhibitor SI113 Sensitizes Theranostic Effects of the 64CuCl2 in Human Glioblastoma Multiforme Cells
Giada Catalogna et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
How Mammalian Cells Acquire Copper: An Essential but Potentially Toxic Metal
Jack H. Kaplan et al.
BIOPHYSICAL JOURNAL (2016)
64Cu2+ Ions as PET Probe: An Emerging Paradigm in Molecular Imaging of Cancer
Rubel Chakravarty et al.
MOLECULAR PHARMACEUTICS (2016)
Role of 64CuCl2 PET/CT in staging of prostate cancer
Enza Capasso et al.
ANNALS OF NUCLEAR MEDICINE (2015)
The role of copper ions in pathophysiology and fluorescent sensors for the detection thereof
Peter Verwilst et al.
CHEMICAL COMMUNICATIONS (2015)
Copper-64 Dichloride as Theranostic Agent for Glioblastoma Multiforme: A Preclinical Study
Cristina Ferrari et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Copper Signaling Axis as a Target for Prostate Cancer Therapeutics
Rachid Safi et al.
CANCER RESEARCH (2014)
Theranostics of Malignant Melanoma with 64CuCl2
Chunxia Qin et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Copper is required for oncogenic BRAF signalling and tumorigenesis
Donita C. Brady et al.
NATURE (2014)
Visualization of Copper Metabolism by 64CuCl2-PET
Hui Wang et al.
MOLECULAR IMAGING AND BIOLOGY (2012)
Positron Emission Tomography of Human Hepatocellular Carcinoma Xenografts in Mice Using Copper (II)-64 Chloride as a Tracer
Haiyuan Zhang et al.
ACADEMIC RADIOLOGY (2011)
Does over-exposure to copper ions released from metallic copper induce cytotoxic and genotoxic effects on mammalian cells?
Claudia A. Grillo et al.
CONTRACEPTION (2010)
Turning Tumor-Promoting Copper into an Anti-Cancer Weapon via High-Throughput Chemistry
F. Wang et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Effects of copper ions released from metallic copper on CHO-K1 cells
C. A. Grillo et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2009)
Molecular imaging with PET
Simon M. Ametamey et al.
CHEMICAL REVIEWS (2008)
Antiangiogenic therapy through copper chelation
M Sproull et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2003)
Share Paper
